Osteoporosis, Vitamin D & Bone Density • ICD-10-CM E55.0
Rickets, active
Audited by the DotMD AI Specialist Council
•
FDA DailyMed SPL: 2026-11-02 • ICD-10-CM E55.0 • 7 Linked .gov / PubMed Citations
•
Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary
Rickets, active Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Designated in federal medical registries as E55.0, Rickets, active falls under Bone Density management, where dual-energy X-ray absorptiometry in Rickets, active (E55.0: (DEXA) with FRAX) establishes baseline severity and rules out diagnostic mimics.
- 2 Real-world patient consensus: Diagnostic registry E55.0: Rickets, active is managed within Bone Density.
- 3 Typical cash cost range: Clinicians assessing Rickets, active focus on cortical porosity [Rickets, active E55.0] and targeted history.
- 4 Top reported side effects / signs: Follow-up benchmark in Rickets, active: maintaining 25-Hydroxy Vitamin D [Rickets, active E55.0] within 40 – 65 ng/mL (E55.0).
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data
3 of 3 Free Questions RemainingAsk our AI Specialists anything about Rickets, active
What Is Rickets, active?
Designated in federal medical registries as E55.0, Rickets, active falls under Bone Density management, where dual-energy X-ray absorptiometry in Rickets, active (E55.0: (DEXA) with FRAX) establishes baseline severity and rules out diagnostic mimics.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Rickets, active (E55.0) features cortical porosity [Rickets, active E55.0]. therapeutic stabilization in bone density is verified against Serum Calcium, Phosphorus in Rickets, active (E55.0: & PTH).
Common Symptoms & Clinical Signs
- • Presentation of Rickets, active (E55.0): fragility fracture of in Rickets, active (E55.0: wrist, hip, or)
- • Secondary Rickets, active clinical sign: gradual loss of in Rickets, active (E55.0: standing height)
- • Symptom flares in Rickets, active correlating with 25-Hydroxy Vitamin D [Rickets, active E55.0] deviation outside 40 – 65 ng/mL (E55.0)
- • Functional bone density impact requiring dual-energy X-ray absorptiometry in Rickets, active (E55.0: (DEXA) with FRAX) evaluation (E55.0)
Rickets, active Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E55.0 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Osteoporosis, Vitamin D & Bone Density | NLM Clinical Tables |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D [Rickets, active E55.0] | 40 – 65 ng/mL (E55.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Calcium, Phosphorus in Rickets, active (E55.0: & PTH) | Ca 8.9–10.1 mg/dL; PTH 15–65 pg/mL (E55.0) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: CTX / P1NP in Rickets, active (E55.0: Bone Turnover Markers) | Balanced remodeling on therapy (E55.0) | Clinical Reference Target Range |
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance
Check Drug Interactions →
FDA-Monographed Medications & Public Cash Price Reference for Rickets, active
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Cleocin Phosphate (Clindamycin Phosphate) Cleocin Phosphate • RxCUI 1737244 | Lincosamide Antibacterial | 90% | $0.1517 | $ 19.42 /mo |
| Periogard Alcohol Free (Chlorhexidine Gluconate) Periogard Alcohol Free • RxCUI 834137 | Decreased Cell Wall Integrity | 88% | $0.0074 | $ 9.03 /mo |
| Prozac (Fluoxetine Hydrochloride) Prozac • RxCUI 104849 | Serotonin Reuptake Inhibitor | 86% | $13.5891 | $ 5.37 /mo |
| Accrufer (Ferric Maltol) Accrufer • RxCUI 2539949 | Parenteral Iron Replacement | 78% | $9.8880 | $ 640.00 /mo |
| Azelastine Hydrochloride and Fluticasone Propionate (Azelastine Hydrochloride, Fluticasone Propionate) Azelastine Hydrochloride and Fluticasone Propionate • RxCUI 1797847-B45802066 | Corticosteroid | 75% | $2.0210 | $ 154.01 /mo |
| Plavix (Clopidogrel) Plavix • RxCUI 213169 | P2Y12 Platelet Inhibitor | 75% | $8.1761 | $ 5.84 /mo |
| Trulicity (Dulaglutide) Trulicity • RxCUI 2395779 | GLP-1 Receptor Agonist | 92% | $478.1755 | $ 640.00 /mo |
| Strattera (Atomoxetine Hydrochloride) Strattera • RxCUI 349592 | Norepinephrine Reuptake Inhibitor | 78% | $12.6575 | $ 9.06 /mo |
| Tofidence (Tocilizumab) Tofidence • RxCUI 2680294 | Interleukin-6 Receptor Antagonist | 84% | $1.5600 | $ 120.82 /mo |
| Elahere (Mirvetuximab Soravtansine) Elahere • RxCUI 2621559 | FDA Prescription Therapeutic Agent | 83% | $3.0500 | $ 228.10 /mo |
| Ziihera (Zanidatamab-Hrii) Ziihera • RxCUI 2698212 | Bispecific HER2-directed Antibody | 93% | $1.7000 | $ 130.90 /mo |
| Nipride Rtu (Sodium Nitroprusside) Nipride Rtu • RxCUI 1876373 | Vasodilator | 85% | $0.8800 | $ 71.86 /mo |
| Enjaymo (Sutimlimab-Jome) Enjaymo • RxCUI 2591425 | Classical Complement Pathway Inhibitor | 82% | $0.6800 | $ 57.46 /mo |
| Felopdipine (Felodipine) Felopdipine • RxCUI 402695-B500907206 | Dihydropyridine Calcium Channel Blocker | 93% | $0.1117 | $ 16.54 /mo |
| Pyrukynd (Mitapivat) Pyrukynd • RxCUI 2594479 | Pyruvate Kinase Activator | 83% | $0.2900 | $ 29.38 /mo |
| Lotronex (Alosetron Hydrochloride) Lotronex • RxCUI 261362 | Serotonin-3 Receptor Antagonist | 79% | $2.5631 | $ 30.28 /mo |
Dr. Lin (AI PubMed Clinical Trial Lead)
Browse All PubMed Translations →
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Rickets, active)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| What the Latest Evidence Really Says About Association Between Statin Use and Daptomycin-related Musculoskeletal side The mixed approach combining a meta-analysis and disproportionality analysis showed that statin use was associated with the occurrence of DAP-related rhabdomyolysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America • 2022-10-12 • Meta-Analysis | Multi-cohort | 86/100 | PMID 35262686 ↗ |
| Can This Approach Help? Inside the Latest Research on Controlled trial of the short-term effect of rosuvastatin on the corrected QT Rosuvastatin single-drug treatment does not appear to increase the risk of arrhythmia. Scientific reports • 2025-09-01 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 40890448 ↗ |
| Can This Approach Help? Inside the Latest Research on Complications of orthopedic treatment in patients diagnosed with X-linked In average, one complication occurred per surgery and the severity of complications were substantial. Journal of pediatric endocrinology & metabolism : JPEM • 2022-08-26 • Phase III Randomized Trial | N = 79 | 82/100 | PMID 35700440 ↗ |
| Can This Approach Help? Inside the Latest Research on Drug interactions between fimasartan and rosuvastatin after single and multiple Getting both at the same time of fimasartan and rosuvastatin did not result in clinically relevant changes in the systemic exposure of fimasartan or rosuvastatin after single and multiple administrations, and they were well... Drug design, development and therapy • 2018-01-15 • Randomized Controlled Trial | Multi-cohort | 82/100 | PMID 29670335 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Diuretic or Calcium-Channel Blocker Plus Angiotensin-Receptor Blocker The combination of losartan and HCTZ is as effective as amlodipine plus ARB in improving LV relaxation in hypertensive patients. Circulation journal : official journal of the Japanese Circulation Society • 2016-01-15 • Randomized Controlled Trial | N = 110 | 82/100 | PMID 26725762 ↗ |
Zero-PHI Patient Support & Cohort Discussions
Rickets, active Patient Community & “People Like Me” Threads
“People Like Me” Cohort Filter (Zero-PHI)
Filter Rickets, active community threads and patient logs by age, biological sex, dosage, and treatment duration.
No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Rickets, active.